Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00462020 · ClinicalTrials.gov registry record · NA
Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis
A NA study, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT00462020 is a NA study that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 102 participants.
The verdict
NCT00462020, a NA study, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
The objective of this study is to scientifically evaluate two different management strategies for perforated appendicitis. The hypothesis is that early discharge with oral antibiotic therapy may result in a dramatic decrease in medical care expenses for the patient. The primary outcome variable between the two strategies is abscess rate.
Interventions
- DRUG 5 days of IV antibiotics (ceftriaxone and metronidazole)
- DRUG Home with oral antibiotics when eating (ampicillin/clavulanic acid)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00462020
The ClinicalTrials.gov registry entry for NCT00462020 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 5 days of IV antibiotics (ceftriaxone and metronidazole) is the first listed.
NCT00462020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00462020 about?
NCT00462020 is a clinical study titled "Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis". The objective of this study is to scientifically evaluate two different management strategies for perforated appendicitis. The hypothesis is that early discharge with oral antibiotic therapy may result in a dramatic decrease in medical care expenses for the patient. The primary outcome variable be...
What is the current status of trial NCT00462020?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2007-03. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00462020?
The interventions under investigation include: 5 days of IV antibiotics (ceftriaxone and metronidazole) (DRUG), Home with oral antibiotics when eating (ampicillin/clavulanic acid) (DRUG).
Who is sponsoring clinical trial NCT00462020?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.